Neil A. Klompas's most recent trade in InMed Pharmaceuticals Inc was a trade of 1,750 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| InMed Pharma Inc | Neil A. Klompas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 1,750 | 5,250 | - | - | Employee Stock Option (Right to Buy) | |
| InMed Pharma Inc | Neil A. Klompas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Oct 2025 | 3,500 | 3,500 | - | - | Employee Stock Option (Right to Buy) |